|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���ʽ�������ø�� |
|
���ʽ�������ø���Ƽ� |
|
Ƥ������ |
| ��������������� | |
|
�Ժ�� |
|
��� |
| PubMed | |
|
Article by ZHAO Heng-guang |
|
Article by LI Hui |
���ʽ�������ø������Ƥ������
�Ժ��, ���
����ҽ�ƴ�ѧ������һҽԺƤ����, 400016
���ʽ�������ø����������ʽ�������ø�������Ƽ�.���߳���Ƥ���������쳣���,��Ƥ��������������������Ϯת�ƹ�ϵ����.�����˹��ϳɵĻ��ʽ�������ø���Ƽ�����ǰ���ٴ������б��ֳ����õĿ�����ЧӦ,�ǵ�ǰ�������������о����ص�����֮һ.
Matrix metalloproteinase family and cutaneous tumors
Department of Dermatology, First Affiliated Hospital, Chongqing University of Medical Science, Chongqing 400016, China
Department of Dermatology, First Affiliated Hospital, Chongqing University of Medical Science, Chongqing 400016, China
The family of matrix metalloproteinase consists of matrix metalloproteinase and their inhibitors. They are often abnormally expressed in cutaneous tumors, and closely related to the growth and invasive metastasis of cutaneous tumors. Some synthesized matrix metalloproteinase inhibitors have shown good anti-tumor effect in early clinical trials. The family has become a focus of the research in prevention and treatment of human tumours.